159 related articles for article (PubMed ID: 26408644)
1. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
Gaspari T; Brdar M; Lee HW; Spizzo I; Hu Y; Widdop RE; Simpson RW; Dear AE
Diab Vasc Dis Res; 2016 Jan; 13(1):56-68. PubMed ID: 26408644
[TBL] [Abstract][Full Text] [Related]
2. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide, a Glucagon-like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
Wang Z; Wang M; Hu X; Li Y; Ma D; Li S; Zhao G; Xie Y; Shu Y; Yang J
Transplantation; 2019 Mar; 103(3):502-511. PubMed ID: 30211824
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.
Sukumaran V; Tsuchimochi H; Sonobe T; Waddingham MT; Shirai M; Pearson JT
Cardiovasc Diabetol; 2020 Feb; 19(1):24. PubMed ID: 32093680
[TBL] [Abstract][Full Text] [Related]
5. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.
Noyan-Ashraf MH; Shikatani EA; Schuiki I; Mukovozov I; Wu J; Li RK; Volchuk A; Robinson LA; Billia F; Drucker DJ; Husain M
Circulation; 2013 Jan; 127(1):74-85. PubMed ID: 23186644
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
[TBL] [Abstract][Full Text] [Related]
7. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
8. Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension.
Yang S; Chen D; Chen F; Zhao X; Zhang Y; Li Z; Jin L; Xu Y; Sanchis D; Ye J
J Hypertens; 2018 Apr; 36(4):834-846. PubMed ID: 29120957
[TBL] [Abstract][Full Text] [Related]
9. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
[TBL] [Abstract][Full Text] [Related]
10. Glucagon Like Peptide-1 Receptor Agonists Alter Pancreatic and Hepatic Histology and Regulation of Endoplasmic Reticulum Stress in High-fat Diet Mouse Model.
Fang T; Huang S; Chen Y; Chen Z; Chen J; Hu W
Exp Clin Endocrinol Diabetes; 2021 Sep; 129(9):625-633. PubMed ID: 32961563
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
[TBL] [Abstract][Full Text] [Related]
14. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
15. CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.
Shen JZ; Morgan J; Tesch GH; Fuller PJ; Young MJ
Endocrinology; 2014 Mar; 155(3):1057-66. PubMed ID: 24428529
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Chen P; Yang F; Wang W; Li X; Liu D; Zhang Y; Yin G; Lv F; Guo Z; Mehta JL; Wang X
J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):179-188. PubMed ID: 32686479
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
[TBL] [Abstract][Full Text] [Related]
18. 5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice.
Wang Y; Li Y; Wu Y; Jia L; Wang J; Xie B; Hui M; Du J
Endocrinology; 2014 Jul; 155(7):2677-87. PubMed ID: 24877626
[TBL] [Abstract][Full Text] [Related]
19. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
[TBL] [Abstract][Full Text] [Related]
20. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL
Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
